What should we do about vaccination of patients on anti-CD20 antibody therapy?
J Neurol Neurosurg Psychiatry
.
2022 Jan;93(1):4.
doi: 10.1136/jnnp-2021-327371.
Epub 2021 Aug 2.
Author
Takayoshi Shimohata
1
Affiliation
1
Department of Neurology, Gifu University Graduate School of Medicine, Gifu, Japan shimohata@gmail.com.
PMID:
34341144
DOI:
10.1136/jnnp-2021-327371
No abstract available
Keywords:
COVID-19.
Publication types
Editorial
Comment
MeSH terms
Humans
Rituximab / therapeutic use
Vaccination*
Substances
Rituximab